Cyril Empig

1.8k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Cyril Empig is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Cyril Empig has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Cyril Empig's work include Viral Infections and Outbreaks Research (6 papers), Hepatitis B Virus Studies (4 papers) and Bacillus and Francisella bacterial research (3 papers). Cyril Empig is often cited by papers focused on Viral Infections and Outbreaks Research (6 papers), Hepatitis B Virus Studies (4 papers) and Bacillus and Francisella bacterial research (3 papers). Cyril Empig collaborates with scholars based in United States, United Kingdom and Slovakia. Cyril Empig's co-authors include Mark A. Goldsmith, Bruce Freimark, Sushil Kumar, Raymond B. Birge, Marc Gurwith, Julie Kenner, Jay W. Carlson, Georg Schett, Martin Herrmann and Sebastian Boeltz and has published in prestigious journals such as Cell, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Cyril Empig

14 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

2016 532 citations Raymond B. Birge, Sebastian Boeltz et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cyril Empig United States	12	589	560	347	302	267	15	1.4k
Paul A Santini United States	8	1.0k 1.7×	524 0.9×	187 0.5×	129 0.4×	140 0.5×	12	1.7k
Hua-Poo Su United States	20	676 1.1×	583 1.0×	199 0.6×	380 1.3×	417 1.6×	33	1.7k
Christian Körner Germany	29	1.1k 1.8×	700 1.3×	159 0.5×	524 1.7×	206 0.8×	52	2.2k
Guy T. Layton United Kingdom	22	794 1.3×	561 1.0×	137 0.4×	321 1.1×	246 0.9×	50	1.7k
Mahfuz Khan United States	15	279 0.5×	450 0.8×	235 0.7×	200 0.7×	372 1.4×	38	1.2k
Anjali Joshi United States	23	433 0.7×	556 1.0×	488 1.4×	358 1.2×	830 3.1×	63	1.6k
Kosuke Miyauchi Japan	23	663 1.1×	545 1.0×	473 1.4×	452 1.5×	744 2.8×	44	1.8k
John Hural United States	18	804 1.4×	544 1.0×	360 1.0×	414 1.4×	619 2.3×	35	1.6k
J A Griffin United States	13	550 0.9×	626 1.1×	406 1.2×	234 0.8×	324 1.2×	18	1.6k
Matthew D. Marsden United States	23	682 1.2×	560 1.0×	665 1.9×	277 0.9×	937 3.5×	42	1.8k

Countries citing papers authored by Cyril Empig

Since Specialization

Citations

This map shows the geographic impact of Cyril Empig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Empig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Empig more than expected).

Fields of papers citing papers by Cyril Empig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Empig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Empig. The network helps show where Cyril Empig may publish in the future.

Co-authorship network of co-authors of Cyril Empig

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Empig. A scholar is included among the top collaborators of Cyril Empig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Empig. Cyril Empig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Steinmetz, Nicole F., Jonathan K. Pokorski, Steven Fiering, et al.. (2021). Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines. Clinical Cancer Research. 27(6_Supplement). S05–2.

2.

Kasikara, Canan, Sushil Kumar, Stanley Kimani, et al.. (2017). Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression. Molecular Cancer Research. 15(6). 753–764. 105 indexed citations

3.

Birge, Raymond B., Sebastian Boeltz, Sushil Kumar, et al.. (2016). Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death and Differentiation. 23(6). 962–978. 532 indexed citations breakdown →

4.

Dowall, Stuart, Victoria Graham, Cyril Empig, et al.. (2015). Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions. Journal of Immunology Research. 2015. 1–9. 15 indexed citations

5.

Dowall, Stuart, David A. Matthews, Isabel García-Dorival, et al.. (2014). Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biology. 15(11). 540–540. 30 indexed citations

6.

Dowall, Stuart, David A. Matthews, Isabel García-Dorival, et al.. (2014). Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome biology. 15(11). 26 indexed citations

7.

Dadachova, Ekaterina, Scott G. Kitchen, Gregory Bristol, et al.. (2012). Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication. PLoS ONE. 7(3). e31866–e31866. 27 indexed citations

8.

Dowall, Stuart, Irene Taylor, Linda Easterbrook, et al.. (2012). Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody. Antiviral Research. 97(2). 108–111. 11 indexed citations

9.

Dadachova, Ekaterina, Scott G. Kitchen, Gregory Bristol, et al.. (2012). Correction: Pre-Clinical Evaluation of a²¹³Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication. PLoS ONE. 7(8). 4 indexed citations

10.

Kennedy, Jeffrey S., Marc Gurwith, Sharon E. Frey, et al.. (2011). Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults. The Journal of Infectious Diseases. 204(9). 1395–1402. 74 indexed citations

11.

Kenner, Julie, Fiona Cameron, Cyril Empig, David V. Jobes, & Marc Gurwith. (2006). LC16m8: An attenuated smallpox vaccine. Vaccine. 24(47-48). 7009–7022. 129 indexed citations

12.

Empig, Cyril, Julie Kenner, Edward F. Bell, et al.. (2005). Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine. 24(17). 3686–3694. 46 indexed citations

13.

Empig, Cyril & Mark A. Goldsmith. (2002). Association of the Caveola Vesicular System with Cellular Entry by Filoviruses. Journal of Virology. 76(10). 5266–5270. 116 indexed citations

14.

Chan, Stephen Y., Cyril Empig, Roberto F. Speck, et al.. (2001). Folate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses. Cell. 106(1). 117–126. 171 indexed citations

15.

Juan, Todd, Eric Hailman, Michael J. Kelley, et al.. (1995). Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64. Journal of Biological Chemistry. 270(10). 5219–5224. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact